Boston Scientific gets FDA OK for 2 heart devices
NATICK, Mass. --Medical device maker Boston Scientific Co. said Tuesday the Food and Drug Administration approved two of its new heart devices.
The FDA approved the Cognis defibrillator and the Teligen implantable defibrillator, both of which are used to treat heart failure.
Shares of Boston Scientific rose 20 cents to $13.21 in after-hours electronic trading, from their close at $13.01 during the regular trading session. 